Related by context. All words. (Click for frequent words.) 80 erlotinib Tarceva ® 79 5 FU leucovorin 78 FOLFOX6 chemotherapy regimen 78 Xeloda ® 77 docetaxel Taxotere R 77 bevacizumab Avastin ® 76 irinotecan doxorubicin oxaliplatin paclitaxel 75 Gemzar ® 75 Aflibercept 75 CYT# potent vascular disrupting 75 thalidomide Thalomid 75 evaluating tivozanib 75 pegylated interferon alfa 2a 75 HGS ETR1 mapatumumab 75 bevacizumab Avastin R 75 sorafenib tablets 75 Fludara ® 75 pegylated liposomal doxorubicin 74 5 fluorouracil leucovorin 74 alfa 2a 74 virus HCV protease inhibitor 74 cyclophosphamide methotrexate 74 dasatinib Sprycel ® 74 AAG geldanamycin analog 74 refractory chronic lymphocytic 74 sorafenib Nexavar 74 docetaxel Taxotere ® 74 evaluating picoplatin 74 evaluating satraplatin 74 pertuzumab 74 MAGE A3 ASCI 74 adriamycin 74 metastatic castration resistant 73 ® lenalidomide 73 lenalidomide Revlimid R 73 sorafenib Nexavar R 73 mapatumumab 73 cisplatin gemcitabine 73 capecitabine Xeloda 73 TO AVOID PREGNANCY WHILE 73 relapsed MM 73 cetuximab Erbitux R 73 chemotherapy FOLFOX 73 bortezomib Velcade R 73 docetaxel chemotherapy 73 paclitaxel Taxol ® 73 cyclophosphamide doxorubicin vincristine 73 lintuzumab SGN 73 orally administered inhibitor 73 Neulasta R 73 sorafenib Nexavar ® 73 FUSILEV enhances 73 R lenalidomide 73 docetaxel Taxotere 73 dextromethorphan quinidine 73 Xelox 73 gemcitabine carboplatin 73 oral prodrug 72 Trastuzumab DM1 72 R Saizen R 72 Fludara 72 Panzem R NCD 72 gemcitabine Gemzar 72 Elotuzumab 72 Peginterferon alfa 2b 72 lexidronam injection 72 gemcitabine chemotherapy 72 telaprevir dosed 72 IMiDs ® 72 Vidaza ® 72 dacarbazine 72 demonstrated antitumor activity 72 imatinib Gleevec ® 72 R sorafenib tablets 72 novel VDA molecule 72 Folfox 72 standard chemotherapy regimen 72 nilotinib Tasigna ® 72 Epothilone D 72 INSPIRE Trial Phase III 72 erlotinib Tarceva R 72 carboplatin paclitaxel 72 low dose cytarabine 71 elotuzumab 71 XL# anticancer compounds 71 ELOXATIN 71 Peg IFN 71 ritonavir boosted 71 Initiates Enrollment 71 mitoxantrone plus 71 progressive metastatic prostate 71 Presents Preclinical Data 71 telomerase therapeutic 71 peginterferon alfa 2b 71 HGS# 71 FEMALES SHOULD BE ADVISED 71 agonistic human 71 YONDELIS 71 dasatinib Sprycel 71 Copegus ribavirin 71 metastatic hormone refractory 71 doxorubicin cyclophosphamide 71 FOLFOX chemotherapy 71 infusional 5-FU/LV 71 alpha interferons 71 intravesical infusion therapy 71 Irinotecan 71 Hsp# Inhibitor 71 SPRYCEL ® 71 Meets Primary Endpoint 71 trastuzumab Herceptin ® 71 pomalidomide 71 FOLFOX6 71 Luveris R Ovidrel R 71 neratinib 71 HER2 positive metastatic breast 71 Completes Patient Enrollment 71 sunitinib Sutent ® 71 metaglidasen 71 ribavirin RBV 71 Seliciclib 71 anthracycline taxane 71 radiation chemoradiation 71 humanised monoclonal antibody 71 Xcytrin R 71 BRAF inhibitor 71 infliximab monotherapy 71 plus prednisone 71 Imprime PGG 71 pegylated interferon alpha 71 vapreotide acetate 71 xenograft models 71 PEGylated anti 71 HGS ETR2 71 Initiates Clinical Trial 71 AVASTIN 71 pan HDAC inhibitor 71 evaluating T DM1 71 GW# [003] 71 non nucleoside inhibitor 71 Phase 2b Clinical Trial 71 nucleoside analog 71 Panzem NCD 71 vinca alkaloid 71 generation Hsp# inhibitor 70 plus Copegus R 70 alkylating agent 70 plus prednisone prednisolone 70 Ovitrelle R Serostim 70 HGS ETR1 70 DEB# 70 Zorbtive TM 70 oral chemotherapeutic agent 70 novel emulsion formulation 70 Crofelemer budesonide foam 70 Pegasys ® 70 recurrent glioblastoma multiforme 70 targeted radiotherapeutic 70 Copegus ® 70 lenalidomide dexamethasone 70 Telik logo TELINTRA 70 CD# CEA 70 PEGylated Fab fragment 70 EOquin TM phase 70 liposomal formulation 70 5 Fluorouracil 70 plus dexamethasone 70 monoclonal antibody IgG1 Mab 70 taxane resistant 70 Copegus R 70 cetuximab Erbitux ® 70 Pemetrexed 70 ACTEMRA TM 70 arsenic trioxide injection 70 oral nucleoside analogue 70 dacarbazine DTIC 70 refractory AML 70 PEGINTRON TM 70 MyVax R 70 alvespimycin 70 candidates Azedra TM 70 Alocrest 70 acetonide FA 70 PKC# 70 Pegasys R 70 dexamethasone Decadron 70 Tarceva TM 70 INCB# [001] 70 interferon gamma 1b 70 plus gemcitabine 70 beta 1a 70 Phase Ib clinical trials 70 LymphoStat B belimumab 70 FOLFIRI 70 OMP #M# 70 2 methoxyestradiol 70 Initiates Phase II 70 MGd 70 Myocet 70 investigational protease inhibitor 70 pan histone deacetylase 70 comparator arm 70 gemcitabine cisplatin 70 MKC# MT 70 somatostatin analog 70 itraconazole Sporanox 70 interferon alfa 2a 70 Epratuzumab 70 LymphoStat B TM 70 prednisone CHOP 70 antibody MAb 70 IMiDs 70 BCG refractory carcinoma 70 receptor tyrosine kinase inhibitor 70 Combination REOLYSIN R 70 Antitumor Activity 69 liposomal doxorubicin 69 TRAIL receptor antibodies 69 essential thrombocythemia ET 69 Mg Usa 69 ATRA IV 69 gefitinib Iressa 69 polyglutamate 69 IMiDs ® compound 69 ALN HPN 69 oncolytic virus therapies 69 ocular formulation 69 Lenocta 69 idarubicin 69 Ixempra 69 bendamustine 69 paclitaxel cisplatin 69 Alkeran 69 unique alkylating agent 69 huC# DM4 69 Personalized Immunotherapy 69 Tibotec Therapeutics division 69 Solazed TM 69 prokinetic agent 69 galiximab 69 pegylated interferon peg IFN 69 HCV NS5B polymerase 69 Dementia Related Psychosis 69 cisplatin vinorelbine 69 CD4 monoclonal antibody 69 Tezampanel 69 bortezomib Velcade 69 recurrent metastatic ovarian cancer 69 q8h 69 Receives Orphan Drug Designation 69 PI3K/Akt pathway inhibitor 69 metastatic colorectal 69 Budesonide foam crofelemer 69 oral picoplatin 69 entinostat 69 TELINTRA 69 Neupogen ® 69 Temsirolimus 69 VELCADE melphalan 69 PSMA ADC 69 ThermoDox R 69 cisplatin carboplatin 69 oral deforolimus 69 Panzem R 69 NS5B polymerase 69 IAP inhibitors 69 Doxil ® 69 Cloretazine ® 69 cediranib 69 alpha 2a 69 Nexavar sorafenib 69 oxaliplatin Eloxatin 69 HSP# inhibitor 69 Sapacitabine 69 IMiDs R 69 Omacetaxine 69 AEG# 69 DOXIL 69 oropharyngeal candidiasis OPC 69 dihydrochloride Tablets 69 TNF Tumor Necrosis Factor 69 estramustine 69 receiving INTRON 69 interferon beta 1a infertility 69 relapsed refractory multiple myeloma 69 developing Bicifadine serotonin 69 Reports Preclinical Data 69 PNP inhibitor 69 refractory CLL 69 Xeloda capecitabine 69 peginterferon alpha 2a 69 potent CYP#A# inhibitors 69 oral ridaforolimus 69 Atripla combines 69 Pertuzumab 69 Taxotere ® 69 sarcoma melanoma 69 trabectedin 69 cyclophosphamide chemotherapy 69 Vidaza R 69 fluoropyrimidine 69 RhuDex R 69 Albuferon TM 69 lenalidomide Revlimid ® 69 familial amyloidotic polyneuropathy FAP 69 cytokine refractory 69 Pegylated interferon 69 chemotherapy fludarabine 69 lumiliximab 69 phase III isavuconazole 69 COPEGUS R 69 PEG SN# 69 sunitinib malate 69 celgosivir 68 Taxotere chemotherapy 68 myelodysplastic myeloproliferative diseases 68 aflibercept VEGF Trap 68 Patients Treated With 68 PegIFN 68 histone deacetylase inhibitor 68 IAP inhibitor 68 anti PlGF 68 TRIOLEX HE# APOPTONE HE# 68 Interferon alfa 2b 68 humanized therapeutic 68 delivers fluocinolone acetonide FA 68 Camptosar ® 68 recurrent NSCLC 68 Mg Uk 68 DNA methyltransferase inhibitors 68 pralatrexate injection folate analogue 68 AKT inhibitor 68 ADP receptor antagonist 68 ALN PCS 68 Campath alemtuzumab 68 IgG1 monoclonal antibody 68 modified glutathione analog 68 Naive Patients 68 daunorubicin 68 kidney urologic 68 stage IIIb IV 68 nab paclitaxel 68 catheter occlusion 68 Azacitidine 68 Complicated Skin 68 Chronic Hepatitis C 68 Leukine ® 68 alfa 2b 68 piperacillin tazobactam 68 proteasome inhibitor 68 DOXIL R 68 TLR9 agonist 68 Novel Oral 68 metastatic colorectal carcinoma 68 Romidepsin 68 Peginterferon Alfa 2a 68 Orally administered 68 oral proteasome inhibitor 68 QUADRAMET R 68 methylnaltrexone bromide 68 leukemia CLL 68 substrates inhibitors 68 combines bupropion 68 Platinol ® cisplatin 68 Pegintron 68 TM Aganocide 68 telaprevir VX 68 Valopicitabine 68 Gemzar gemcitabine 68 Abiraterone acetate 68 cilengitide 68 Hormone Refractory Prostate Cancer 68 VEGFR2 inhibitor 68 chemotherapy cisplatin 68 TBC# 68 Navelbine ® 68 cMET 68 Sustiva efavirenz 68 investigational monoclonal antibody 68 GVAX ® 68 Initiates Phase III 68 Chemophase 68 tenofovir emtricitabine 68 ® bortezomib 68 SinuNase TM 68 EGFR tyrosine kinase inhibitor 68 brand ciclesonide HFA 68 ceftazidime 68 Velcade bortezomib 68 mertansine 68 IL# PE#QQR 68 Gemcitabine 68 pegylated interferon alfa 2b 68 mRCC 68 forodesine 68 TLK# 68 evaluating Xcytrin 68 pegylated interferons 68 alpha 2b 68 PROSTASCINT R 68 advanced metastatic renal 68 IMPDH inhibitor 68 relapsed acute myelogenous 68 vinca alkaloids 68 hypoxia selective 68 Cloretazine 68 peginterferon alfa 2a Pegasys 68 Peginterferon 68 Myelodysplastic Syndrome MDS 68 Presents Preclinical 68 Glufosfamide 68 potent triglyceride lowering 68 Initiate Phase 68 adalimumab Humira 68 Vaccine Adjuvant 68 R metformin Concor 68 By JENNIFER LEARN 68 Anti Tumor 68 zoledronate 68 iniparib 68 novel topoisomerase 68 adecatumumab 68 PORxin TM platforms 68 Nexavar ® 68 Recombinant Human 68 TRANSDUR ® 68 EGFr expressing metastatic colorectal 68 polymerase inhibitor 68 Granulocyte Colony Stimulating Factor 68 refractory multiple myeloma 68 pathophysiological effects 68 PREZISTA r 68 IGF 1R inhibitor 68 tenofovir Viread 68 RhuDex TM 68 Pruvel TM 68 non resectable metastatic 68 evaluating mipomersen 68 tumor xenograft models 68 Pharma Merck Serono 68 drug pipeline TAFA# 68 COPEGUS ribavirin 68 sapropterin dihydrochloride 68 Omnitarg 68 DexaSite 68 Initiate Clinical Trial 68 paclitaxel Taxol 68 Pivotal Phase 68 xanthine oxidase inhibitor 68 boosted protease inhibitor 67 melphalan prednisone 67 relapsed myeloma 67 EndoTAGTM 1 67 FOLOTYN ® 67 panitumumab Vectibix R 67 Bezielle 67 oral levofloxacin 67 lymphoid malignancies 67 treatment naïve genotype 67 Aptivus ® 67 baminercept 67 adecatumumab MT# 67 AzaSite Plus 67 5-FU/LV 67 Phase IIb Clinical Trial 67 MCSP respectively 67 Refractory Hodgkin Lymphoma 67 Clolar ® 67 topically applied SEPA 67 hormone refractory metastatic prostate 67 RG# ITMN 67 ritonavir boosted atazanavir 67 Amrubicin 67 pharmacokinetic equivalence 67 Interferon alfa 67 Pegasys peginterferon alfa 2a 67 decitabine 67 colesevelam HCl 67 Brentuximab Vedotin SGN 67 TORISEL 67 Gilead Viread 67 metformin sulfonylurea 67 Proxinium TM 67 R rilonacept Injection 67 midstage clinical 67 Pruvel ™ 67 Rebif ® 67 COLAZAL R 67 Vitrasert R 67 PREZISTA rtv 67 histone deacetylase HDAC inhibitor 67 Phase 1b clinical trials 67 targeting CD# 67 PROSTVAC VF 67 neutropenia dehydration dyspnea 67 lopinavir r 67 Bortezomib 67 irinotecan containing 67 Navelbine 67 pemetrexed Alimta 67 Paraplatin ® 67 pharmacogenomic translational research 67 aerosolized AAT 67 leukemia AML 67 K ras mutations 67 multi kinase inhibitor 67 toenail onychomycosis 67 oblimersen 67 compound INCB# 67 lesinurad 67 Pegylated Interferon 67 Taxotere docetaxel 67 Preclinical Study 67 placebo dexamethasone 67 Liprotamase 67 MKC# MKC# PP 67 μg dose 67 mGluR5 negative 67 Vitaxin 67 Zolinza 67 BARACLUDE R 67 Metastatic Melanoma 67 metabolic disorders Saizen R 67 valopicitabine 67 TNF alpha selectively neutralizing 67 R# #mg BID 67 Deforolimus 67 interferon ribavirin 67 Xanafide 67 evaluating REVLIMID 67 CYP#A# CYP#D# 67 Temodar ® 67 Annamycin 67 Diovan Exforge Tekturna Zelnorm 67 Granted Orphan Drug 67 inhibitor RG# 67 INVANZ 67 Proellex TM 67 carcinoma mCRC 67 Racivir 67 SPL# Gel vaginal microbicide 67 VEGF inhibitors 67 NXL# 67 TKB# 67 relapsed multiple myeloma 67 markets COLAZAL 67 hormone LHRH antagonist 67 Ceflatonin R 67 HMG CoA reductase inhibitors 67 ZOLINZA 67 IMA# 67 nilotinib Tasigna 67 Voreloxin 67 FOLFOX4 67 Randomized Phase 67 nucleoside reverse transcriptase inhibitor 67 CIMZIA ™ 67 cutaneous T 67 abacavir lamivudine 67 induced macular edema 67 motexafin gadolinium Injection 67 regorafenib 67 Achieves Primary Endpoint 67 docetaxel Injection Concentrate 67 metastatic renal cell carcinoma 67 Phase IIb Trial 67 FUSILEV ® 67 etanercept Enbrel 67 MEK Inhibitor 67 Luteinizing Hormone Releasing Hormone 67 Ophena TM 67 Phase #b/#a clinical 67 thiazolides 67 headache nasopharyngitis 67 Trial Evaluating 67 CCR5 mAb 67 metastatic GIST 67 hypoxia activated prodrug 67 Daclizumab 67 AZT zidovudine Retrovir 67 OvaRex R 67 Traficet EN 67 HCV RNA polymerase 67 amprenavir 67 paclitaxel Taxol R 67 trastuzumab DM1 67 myelofibrosis polycythemia vera 67 Chronic Lymphocytic Leukemia CLL 67 Nexavar sorafenib tablets 67 HCV SPRINT 67 Vascular Disrupting Agent 67 Serostim ® 67 formerly LymphoStat B 67 mg q#h 67 Ribavirin causes 67 axitinib 67 posaconazole 67 mTOR mammalian target 67 hypertrichosis occurred 67 visilizumab 67 BR.# 67 volociximab 67 Pharmacokinetics PK 67 Eraxis 67 PRN FDA Approves 67 sunitinib Sutent 67 lintuzumab 67 Platinol ® 67 KRN# 67 NEUPOGEN R 67 gemcitabine Gemzar ® 67 hydroxymethyl coenzyme 67 huN# DM1 67 metastatic castrate resistant 67 patients coinfected 67 alpha folate receptor 67 fosbretabulin 67 REVLIMID ® 67 PEGylated interferon beta 1a 67 microtubule inhibitor 67 fluoroquinolone class 67 Interferon alpha 67 phase IIb clinical 67 Targretin 67 CANCIDAS 67 XL# XL# 67 Zevalin R Ibritumomab 67 OncoVex 67 milatuzumab 67 Elvitegravir 67 refractory metastatic 67 hA# 67 mg RDEA# 67 topical gel formulation 67 gastrin analogue TT 67 Cytarabine 67 phase IIb trial 67 Thiarabine 67 non metastatic resectable 67 PD LID 67 CIMZIA TM 67 IRX 2 67 Torisel temsirolimus 67 Mitoxantrone 67 #mg BID [003] 67 chemotherapeutic agents carboplatin 67 pegylated interferon alpha 2a 67 Cutaneous T 67 HCV polymerase inhibitors 67 chemotherapy gemcitabine 67 chimeric monoclonal antibody 67 Capesaris 67 EMD # 67 Talabostat 67 Initiates Clinical 67 Intravitreal injections 67 chemosensitizer 67 Nitazoxanide 67 Tanespimycin 67 personalized cellular immunotherapy 67 CYT# vascular disrupting 67 Investigational Oral 66 INCB# [003] 66 Immunotherapeutic 66 PDX pralatrexate 66 vinorelbine tartrate 66 substantially excreted 66 Kinase Inhibitor 66 Vinorelbine 66 ergot derivatives 66 interleukin IL -# 66 HER1 66 azilsartan medoxomil 66 First Patient Dosed 66 chemotherapy molecularly targeted 66 R roscovitine CDK cyclin 66 PF # [002] 66 azoles 66 gastrointestinal disorders ATI 66 thymalfasin 66 Cloretazine R VNP#M 66 anti EGFR antibody 66 epirubicin cyclophosphamide 66 TRX1 66 tigecycline 66 RANK Ligand inhibitor 66 lapatinib Tykerb 66 Amplimexon 66 Tiuxetan 66 AVE# 66 Amgen Neulasta R 66 CHOP cyclophosphamide doxorubicin vincristine 66 panitumumab Vectibix 66 Tesmilifene 66 Zenvia ™ 66 Belimumab 66 Peginterferon alfa 2a 66 Obatoclax 66 MEK inhibitor 66 interferon alfacon 1 66 peripherally acting 66 systemic ALCL 66 Aurora Kinase 66 Archexin 66 Herceptin trastuzumab 66 prostate cancer HRPC 66 unresectable stage 66 D aspartate NMDA receptor 66 budesonide foam 66 pentadentate logo R 66 IMC A# 66 PROVENGE ® 66 Shows Statistically Significant 66 Phase 1b trial 66 sargramostim 66 selective modulator 66 refractory cutaneous T 66 Palifosfamide 66 pentostatin 66 mycophenolate mofetil 66 Vandetanib 66 intranasal formulation 66 WX UK1 66 Rigel R# 66 imatinib Gleevec 66 Receives Fast Track 66 Submits Biologics License Application 66 ELACYT 66 Gleevec imatinib mesylate 66 Study Evaluating 66 Jevtana 66 TELCYTA 66 investigational oral inhibitor 66 acyclovir Lauriad R 66 Lenocta TM 66 somatropin Kuvan R 66 SAR# [002] 66 INTEGRILIN R 66 systemic RNAi therapeutic 66 luteinizing hormone releasing 66 sapacitabine CYC# 66 relapsed leukemia 66 OvaRex ® MAb 66 cetuximab Erbitux 66 allosteric modulator NAM 66 YONDELIS R 66 custirsen 66 accumulate preferentially 66 humanized interleukin 6 66 Intravitreal 66 BRIM2 66 non peptidic protease 66 R bisoprolol Euthyrox 66 novel nucleoside analog 66 carboplatin chemotherapy 66 Fludarabine 66 CA4P 66 multicenter Phase III 66 REG1 Anticoagulation System 66 Amigal TM 66 Solorel TM 66 products MKC# PP 66 valtorcitabine 66 albiglutide 66 EGFr humanized monoclonal antibody 66 3TC lamivudine Epivir 66 Exelixis compounds 66 trastuzumab Herceptin 66 Sphingomab TM 66 adenosine injection 66 urocortin 2 66 PXD# 66 FOLFOX 66 FDA APPROVES 66 trastuzumab DM1 T DM1 66 ixabepilone 66 lenalidomide Revlimid 66 signal transduction inhibitors 66 folinic acid 66 cell carcinoma RCC 66 Genasense ® 66 Relapsed Refractory 66 alefacept 66 multiple myeloma MM 66 CCX# 66 interferon alfa 2b 66 Ozarelix 66 KRAS mutations occur 66 biologic DMARD 66 targeted antifolate 66 metformin sulfonylureas 66 Romiplostim 66 pharmacologically active isomer 66 PEGylated interferon 66 TELINTRA R 66 Vicriviroc 66 castrate resistant prostate cancer 66 deforolimus 66 radiation sensitizer 66 FluCAM 66 intra arterial chemotherapy 66 Campath ® 66 JAK2 Inhibitor 66 Wafer polifeprosan 66 systemic anaplastic large 66 reslizumab 66 EDEMA3 trial 66 Genentech Rituxan 66 Flu Cy 66 CDK cyclin dependent 66 CTAP# Capsules 66 Zalypsis 66 Thiovir 66 Etoposide 66 GMX# 66 rosuvastatin #mg 66 capecitabine Xeloda R 66 Pegloticase 66 temsirolimus 66 cytarabine daunorubicin 66 NU# direct 66 Initiates Phase 2b 66 investigational oral hepatitis C 66 Zybrestat 66 OMP #R# 66 aspirin clopidogrel 66 triggers apoptosis programmed 66 Telintra 66 Solazed ™ 66 IMiD 66 GlaxoSmithKline Tykerb 66 coronary stent merged 66 Genasense ® oblimersen 66 radezolid 66 unresectable tumors 66 PSN# [002] 66 primary hypercholesterolemia 66 telomerase inhibitor drug 66 mitogen activated ERK kinase 66 Alfacell proprietary ribonuclease 66 hereditary emphysema 66 Doxil 66 BCR ABL inhibitors 66 Amgen Neulasta ® 66 Eluting Stent 66 antimetabolite 66 Completes Enrollment 66 IV Busulfex 66 Roche Pegasys 66 Multiple Ascending Dose 66 viral kinetics 66 TRO# 66 small molecule tyrosine 66 selective immunoproteasome inhibitor 66 HuLuc# 66 targets EpCAM expressing 66 novel immunomodulatory 66 interferon alfa 66 iobenguane 66 Alinia 66 SinuNase ™ 66 Initiates Phase 66 Antigen Specific 66 small molecule Hedgehog 66 vorinostat 66 PEG Interferon lambda 66 systemically administered 66 estrogen receptor antagonist 66 Biogen Genentech 66 RhuDex ® 66 KNS # 66 azathioprine monotherapy 66 Multiple Myeloma MM 66 ENMD # 66 irinotecan chemotherapy 66 MabCampath 66 markets HP Acthar 66 Golimumab 66 LHRH receptor positive 66 hyaluronidase enzyme 66 dependent kinase inhibitor 66 Blinatumomab 66 Anti Tumor Activity 66 Prolongs Survival 66 treatment naive genotype 66 evaluating carfilzomib 66 Tibotec BVBA 66 bevacizumab Avastin 66 CHOP chemotherapy 66 anthracyclines taxanes 66 saline placebo 66 tanespimycin 66 LEXIVA r 66 metastatic androgen independent 66 Sudhir Agrawal D.Phil 66 goserelin 66 investigational humanized monoclonal antibody 66 Fc fusion protein 66 plus dacarbazine 66 MT#/MEDI-# 66 indinavir Crixivan 66 Epothilones 66 BARACLUDE ® 66 Files IND 66 Adjuvant Treatment 66 Anti VEGF 66 HBeAg negative 66 intravenous belinostat 66 oral dihydropyrimidine dehydrogenase DPD 66 Parkinson disease levodopa induced 66 diarrhea predominant irritable 66 class mGluR5 inhibitor 66 EPIVIR 66 SUPPRELIN R LA 66 XL# XL# XL# XL# 66 saquinavir ritonavir 66 pregabalin Lyrica 66 oral antidiabetic 66 Imprime PGG ® 66 HDAC Inhibitor 66 superficial bladder cancer 66 prednisone prednisolone plus 66 standard chemotherapy regimens 66 JAK1 66 Ridaforolimus 66 fluvastatin 66 administered concomitantly 66 samarium Sm 66 Aurexis R 66 plasma kallikrein inhibitor 66 HCV protease inhibitors 66 Bosutinib 66 FOLFIRI chemotherapy 66 investigational pharmacologically unique 66 telaprevir pegylated interferon 66 peptidic compound 66 folinic acid FA 66 nalbuphine ER 66 ZACTIMA 66 ThermoDox ® clinical 66 8mg/kg 66 CHEAP ONLINE PHARMACY LOW 66 Allovectin 7 66 Allovectin 7 ® 66 PDE4 inhibitor 66 nonnucleoside reverse transcriptase inhibitor 66 Melphalan 66 Methylnaltrexone 65 bone marrow reticulin deposition 65 torsemide ER 65 PrevOnco ™ 65 vincristine doxorubicin 65 q#h 65 cromolyn sodium 65 benign prostatic hypertrophy BPH 65 Pivotal Phase III 65 NS#/#A protease 65 mitomycin 65 EGFR expressing mCRC 65 trastuzumab emtansine T DM1 65 treat chronic sinusitis 65 abacavir sulfate lamivudine 65 ACTIQ ® 65 meropenem 65 Begins Dosing 65 octreotide acetate 65 Onalta ™ 65 Tipranavir 65 MT# MEDI 65 PANVAC VF 65 Bayer HealthCare Onyx Pharmaceuticals 65 Taxol paclitaxel 65 5 fluorouracil 65 registrational Phase 65 Pfizer Camptosar 65 Bevacizumab 65 5 FU capecitabine 65 non nucleoside HCV 65 Provectus Pharmaceuticals specializes 65 PRT# 65 OXi# 65 ara C 65 Investigational Treatment 65 cell lymphoma CTCL 65 bladder ovarian 65 successfully commercialize Iluvien 65 Erlotinib 65 Cetuximab Erbitux 65 Onalta TM 65 stage IIIB 65 small molecule thrombopoietin 65 CINTREDEKIN BESUDOTOX 65 gemcitabine Gemzar R 65 Imetelstat 65 including eniluracil ADH 65 busulfan 65 Pivotal Study 65 herpetic keratitis 65 candidates Azedra